Market Indices
Latest News
 |
|
Price Targets
Eric Coldwell from Robert W. Baird issued a price target of $1.50 for ACH on 2026-08-11 06:49:00.The adjusted price target was set to $1.50.At the time of the announcement,...
August 11, 2026 ACH -52.70%
Swayampakula Ramakanth from H.C. Wainwright issued a price target of $7.00 for IPHA on 2026-08-10 16:27:19.The adjusted price target was set to $7.00.At the time of the announcement,
August 10, 2026 IPHA 28.32%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| STKH Steakholder Foods Ltd. | 4.30
128.72% | ||||||||||||||||||
| SLN Silence Therapeutics plc | 15.43
29.12% | ||||||||||||||||||
| IPHA Innate Pharma S.A. | 2.22
28.32% | ||||||||||||||||||
| BNR Burning Rock Biotech Limi | 10.86
23.27% | ||||||||||||||||||
| QH Quhuo Limited | 5.08
15.85% | ||||||||||||||||||
| QNRX Quoin Pharmaceuticals, Lt | 5.36
11.90% | ||||||||||||||||||
| FRSX Foresight Autonomous Hold | 1.36
11.48% | ||||||||||||||||||
| LU Lufax Holding Ltd | 1.66
11.41% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 6.52%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 2.50%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA 2.50%